Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR, Roberts IA, Yeager AM, Hsu L, Adamkiewicz T, et al; Multicenter Investigation of Bone Marrow Transplantation for Sickle Cell Disease. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 2001;7:665 673. doi: 664. Fryer RH, Anderson RC, Chiriboga CA, Feldstein NA. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. Pediatr Neurol. 665. Hankinson TC, Bohman LE, Heyer G, Licursi M, Ghatan S, Feldstein NA, Anderson RC. Surgical treatment of moyamoya syndrome in pa- tients with sickle cell anemia: outcome following encephaloduroarte- riosynangiosis. J Neurosurg Pediatr. 2008;1:211 216. doi: 10.3171/ 666. Pleasants S. Epidemiology: a moving target. Nature. 2014;515:S2 S3. doi: 667. Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. 668. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, Temperley WH, Williams TN, Weatherall DJ, Hay SI. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381:142 151. doi: 669. Adams RJ, Nichols FT, McKie V, McKie K, Milner P, Gammal TE. Cerebral in- farction in sickle cell anemia: mechanism based on CT and MRI. Neurology. 670. Mack AK, Thompson AA. Primary and secondary stroke prevention in chil- dren with sickle cell disease. J Pediatr Health Care. 2017;31:145 154. 671. DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 672. Brekke LK, Diamantopoulos AP, Fevang BT, A mus J, Esper E, Gjesdal CG. Incidence of giant cell arteritis in western Norway 1972- 2012: a retrospective cohort study. Arthritis Res Ther. 2017;19:278. doi: 673. 